ClinicalTrials.gov
ClinicalTrials.gov Menu

Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01464762
Expanded Access Status : Approved for marketing
First Posted : November 4, 2011
Last Update Posted : November 27, 2017
Sponsor:
Information provided by (Responsible Party):
Janssen Infectious Diseases BVBA

No Study Results Posted on ClinicalTrials.gov for this Study
  Expanded Access Status : Approved for marketing
  Primary Completion Date : No date given
  Study Completion Date : No date given